Alcon Inc. income statement ALC

Annual Quarterly

In fiscal 2025, which ended Dec 31, 2025, Alcon Inc. reported revenue of $10.3 billion, up 4.9% from the year before. Net income was $980.0 million, a profit margin of 9.5%. Operating income came to $1.4 billion, an operating margin of 13.2%. Diluted earnings per share were $1.98. Across the 9 fiscal years shown, revenue grew from $6.5 billion in fiscal 2009 to $10.3 billion in fiscal 2025, about 5.9% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020	FY 2019 Dec 31, 2019	FY 2010 Dec 31, 2010	FY 2009 Dec 31, 2009
Revenue	10,319 +4.9%	9,836 +5.0%	9,370 +8.3%	8,654 +5.3%	8,222 +21.6%	6,763 -8.1%	7,362	7,179 +10.5%	6,499
Cost of revenue	4,592 +6.1%	4,328 +4.5%	4,141 +5.9%	3,910 +9.3%	3,577 -6.6%	3,830 +3.0%	3,719	1,675 +3.8%	1,614
Gross profit	5,745 +4.2%	5,512 +5.1%	5,247 +10.5%	4,748 +2.1%	4,652 +58.2%	2,940 -19.7%	3,662	5,504 +12.7%	4,885
Research and development	990 +13.0%	876 +5.8%	828 +17.9%	702 -16.6%	842 +25.1%	673 +2.6%	656	747 +12.3%	665
Selling, general and administrative	3,449 +6.1%	3,250 +1.3%	3,209 +4.6%	3,068 -0.3%	3,076 +14.2%	2,694 -5.4%	2,847	—	—
Operating income	1,360 -3.8%	1,413 +36.0%	1,039 +54.6%	672 +15.9%	580 +220.3%	-482 -157.8%	-187	—	—
Pretax income	1,160 -7.6%	1,256 +51.0%	832 +79.7%	463 +10.8%	418 +165.8%	-635 -91.3%	-332	2,527 +9.3%	2,313
Income tax	180 -24.4%	238 +267.6%	-142 -210.9%	128 +204.8%	42 +140.4%	-104 -132.1%	324	—	—
Net income	980 -3.7%	1,018 +4.5%	974 +190.7%	335 -10.9%	376 +170.8%	-531 +19.1%	-656	2,210 +10.1%	2,007
Basic EPS	1.99 -3.4%	2.06 +4.0%	1.98 +191.2%	0.68 -11.7%	0.77 +170.6%	-1.09 +18.7%	-1.34	—	—
Diluted EPS	1.98 -3.4%	2.05 +4.6%	1.96 +188.2%	0.68 -10.5%	0.76 +169.7%	-1.09 +18.7%	-1.34	—	—
Weighted average shares, basic	493 -0.2%	494 +0.3%	493 +0.3%	491 +0.3%	490 +0.2%	489 +0.2%	488	—	—
Weighted average shares, diluted	496 -0.3%	498 +0.2%	496 +0.4%	494 +0.2%	493 +0.9%	489 +0.2%	488	—	—
Other measures
Depreciation and amortization	—	—	—	—	—	—	—	212 +9.3%	194
Interest coverage	6.67x	7.36x	5.50x	5.01x	4.83x	-3.89x	-1.65x	—	—
Margins
Gross margin	55.67%	56.04%	56.00%	54.86%	56.58%	43.47%	49.74%	76.67%	75.17%
Operating margin	13.18%	14.37%	11.09%	7.77%	7.05%	-7.13%	-2.54%	—	—
Pretax margin	11.24%	12.77%	8.88%	5.35%	5.08%	-9.39%	-4.51%	35.20%	35.59%
Profit margin	9.50%	10.35%	10.39%	3.87%	4.57%	-7.85%	-8.91%	30.78%	30.88%
Effective tax rate	15.52%	18.95%	-17.07%	27.65%	10.05%	—	—	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Ophthalmic Goods (SIC 3851)
Listed as: ALC (NYSE)
Fiscal year ends: December 31
Incorporated in: Switzerland
Headquarters: Fort Worth, TX
SEC filer status: Large accelerated filer
SEC CIK: 1167379

Other Ophthalmic Goods companies

All 8 Ophthalmic Goods companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.